Geojit Research has issued an ACCUMULATE rating on Tata Chemicals Limited with a revised target price of Rs 876 per share.
News in Focus


Ventura Securities Limited has issued a BUY recommendation for DCB Bank Limited, setting a compelling target price of Rs 228 over the next 24 months, implying a robust 33.8% upside from the current

Motilal Oswal Financial Services has reiterated a BUY rating on Kajaria Ceramics with a target price of Rs 1,252, implying upside potential of about 19 percent from the current market price of Rs 1

Geojit Financial Services has reiterated its BUY recommendation for Bajaj Finance Limited, projecting a revised target price of Rs 1,138 from the current market price of Rs 1,015,

Axis Securities has issued a BUY recommendation on Shriram Finance Limited, establishing an ambitious target price of Rs 1,125 per share—representing a compelling 25% upside from t

Phoenix Mills Limited, India's premier retail-led mixed-use development company, has received a BUY call from ICICI Securities with an ambitious target price of Rs 2,210, representing a compelling
Main Regional Stories

ICICI Securities Retail Equity Research has issued a BUY recommendation on Shriram Finance (SHRTRA), with a compelling target price of Rs 1,200 over a 12-month horizon, implying substantial upside from the current market price around Rs 925.

The rise of live casino game shows in India has changed how people experience online gambling. Players are no longer just clicking buttons and waiting for outcomes.

ICICI Securities has reiterated its BUY rating on Axis Bank, projecting a resilient earnings trajectory despite a deliberate trade-off between net interest margin (NIM) and balance sheet expansion.

ICICI Direct has reiterated its BUY call on KPIT Technologies, projecting a 12‑month target price of Rs 1,475 versus a current market price of Rs 1,223, implying upside potential of about 21 percent for investors willing to ride out near-term vola
action witnessed unstable mo
The BSE 30-share Sensex penetrated the sensitively important 15,000 mark
New Delhi:
Mumbai: SBI Mutual Fund has crossed Rs 20,000-crore mark in assets under
In early trade, Dabur Pharma was trading up 1.51% to Rs 77.50 after 50 lakh







